An observational study in Warts, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-15.
Sponsored by Assiut University · Observational
Among 17 studies in Warts by Assiut University — 8 open to participants now, 8 under way, 3 of them phase 3. Warts · Assiut University.
Among the 17 studies in Warts by Assiut University, this one is the only one that started in 2025, is one of 2 observational ones, and was the 14th registered.
171 studies on the registry are indexed under Warts; 35 are open to participants now.
This study's planned enrollment of 60 is below the median of 100 across 11 observational studies indexed under Warts.
Browse Warts studies →8 of the 17 studies in Warts by Assiut University are open now.
Of the 18 Warts studies recruiting now, 10 (56%) set no upper age limit and 8 (44%) stop at 75 or younger; 12 take children under 18; 1 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · healthy volunteers too.
The full table on the hub →17 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 1 started in 2025.
Median enrollment 68 across the 15 interventional studies, 80 across the 2 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
4 of the studies in Warts by Assiut University that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07830979Phase 3Assiut UniversityHydrogen Peroxide 40% Versus Salicylic Acid 40% for Plantar Warts | 2027-09-20 |
| NCT07848100Phase 3Assiut UniversityIntralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts | 2027-10 |
| NCT07396714Assiut Universitythe Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts. | 2027-02-01 |
| NCT07041749Assiut UniversityMicroneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts | 2027-06-01 |
Among the 17 studies in Warts by Assiut University, from their registry updates:
To assess the clinical efficacy and safety of topical imiquimod 5% cream combined with cryotherapy versus either of theme alone for the treatment of common warts by clinical and dermoscopic assessments.
Topical Imiquimod 5% cream Combined with Cryotherapy Versus either of them alone in Treatment of Common Warts: A prospective Randomized Comparative Trial
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Complete clearance rate of common warts.
Assessment of complete warts clearance rate at 12weeks to evaluate the efficacy of combination therapy ( imiquimod5%cream+cryotherapy ) compared to topical imiquimod5%cream alone or cryotherapy alone in patients with common wart.
Time frame: 12 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.